Medesis Pharma (France) Buy Hold or Sell Recommendation
| ALMDP Stock | EUR 0.43 0.01 2.38% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Medesis Pharma SA is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Medesis Pharma SA given historical horizon and risk tolerance towards Medesis Pharma. When Macroaxis issues a 'buy' or 'sell' recommendation for Medesis Pharma SA, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Medesis Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Medesis and provide practical buy, sell, or hold advice based on investors' constraints. Medesis Pharma SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Medesis |
Execute Medesis Pharma Buy or Sell Advice
The Medesis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Medesis Pharma SA. Macroaxis does not own or have any residual interests in Medesis Pharma SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Medesis Pharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Medesis Pharma Trading Alerts and Improvement Suggestions
| Medesis Pharma SA generated a negative expected return over the last 90 days | |
| Medesis Pharma SA has high historical volatility and very poor performance | |
| Medesis Pharma SA has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 95.73 K. Net Loss for the year was (2.65 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| About 17.0% of the company shares are held by company insiders |
Medesis Pharma Returns Distribution Density
The distribution of Medesis Pharma's historical returns is an attempt to chart the uncertainty of Medesis Pharma's future price movements. The chart of the probability distribution of Medesis Pharma daily returns describes the distribution of returns around its average expected value. We use Medesis Pharma SA price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Medesis Pharma returns is essential to provide solid investment advice for Medesis Pharma.
| Mean Return | -0.29 | Value At Risk | -16.19 | Potential Upside | 16.22 | Standard Deviation | 10.93 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Medesis Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Medesis Pharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Medesis Pharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Medesis Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Medesis stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.4 | |
β | Beta against Dow Jones | 0.84 | |
σ | Overall volatility | 7.88 | |
Ir | Information ratio | -0.04 |
Medesis Pharma Volatility Alert
Medesis Pharma SA is displaying above-average volatility over the selected time horizon. Medesis Pharma SA is a potential penny stock. Although Medesis Pharma may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Medesis Pharma SA. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Medesis instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Medesis Pharma Fundamentals Vs Peers
Comparing Medesis Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Medesis Pharma's direct or indirect competition across all of the common fundamentals between Medesis Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Medesis Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Medesis Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Medesis Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Medesis Pharma to competition |
| Fundamentals | Medesis Pharma | Peer Average |
| Current Valuation | 8.67 M | 16.62 B |
| Shares Outstanding | 4.39 M | 571.82 M |
| Shares Owned By Insiders | 17.28 % | 10.09 % |
| Price To Book | 74.91 X | 9.51 X |
| Price To Sales | 189.31 X | 11.42 X |
| Revenue | 95.73 K | 9.43 B |
| EBITDA | (3.05 M) | 3.9 B |
| Net Income | (2.65 M) | 570.98 M |
| Cash And Equivalents | 2.89 M | 2.7 B |
| Total Debt | 1.28 M | 5.32 B |
| Earnings Per Share | (0.74) X | 3.12 X |
| Target Price | 4.1 | |
| Number Of Employees | 3 | 18.84 K |
| Market Capitalization | 13.43 M | 19.03 B |
| Total Asset | 4.33 M | 29.47 B |
| Z Score | 6.0 | 8.72 |
| Net Asset | 4.33 M |
Medesis Pharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Medesis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Medesis Pharma Buy or Sell Advice
When is the right time to buy or sell Medesis Pharma SA? Buying financial instruments such as Medesis Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Medesis Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Chemicals Thematic Idea Now
Chemicals
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Chemicals theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Chemicals Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Medesis Stock Analysis
When running Medesis Pharma's price analysis, check to measure Medesis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medesis Pharma is operating at the current time. Most of Medesis Pharma's value examination focuses on studying past and present price action to predict the probability of Medesis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medesis Pharma's price. Additionally, you may evaluate how the addition of Medesis Pharma to your portfolios can decrease your overall portfolio volatility.